Notice of Intent to Sole Source - Minneapolis VA Medical Center - FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers   2

This Notice of Intent is provided to advise that the Government intends to solicit and negotiate a sole source, Firm Fixed Price contract with option periods with only one source, Microgenics Corporation, to provide FDA-Approved Microgenics DRI Ecstasy Plus Assay Reagent used with Beckman AU480 Analyzers for the Minneapolis VA Medical Center. This contract action is for supplies for which the Government intends to solicit and negotiate a Sole Source award under the authority of FAR 13.106-1. This notice of intent to award a sole source contract is not a request for competitive proposals. However, in accordance with FAR 5.207 (c) (16) (ii), all responsible sources that feel they can meet the Government s requirements detailed above may submit a capability statement which shall be considered by the agency. Responses to this notice shall contain sufficient information to establish the interested parties bona-fide capabilities for fulfilling the requirement and include: the System for Award Management (SAM) Unique Entity ID (UEI), and the Taxpayer Identification Number (TIN), along with documentation that the vendor is an authorized distributor/reseller. All offerors must have an active registration in SAM at www.sam.gov. A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information will be retained as Market Research. All responses must be received by 12:00 PM Central Time on Thursday, January 9, 2025. Responses shall be submitted electronically to Alisha Milander via email at Alisha.Milander@va.gov. Fax responses and Telephone inquiries will not be accepted.